Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Other Non-Current Liabilities (2019 - 2022)

Argan's Other Non-Current Liabilities history spans 7 years, with the latest figure at $4.5 million for Q2 2022.

  • On a quarterly basis, Other Non-Current Liabilities rose 20.9% to $4.5 million in Q2 2022 year-over-year; TTM through Apr 2022 was $4.5 million, a 20.9% increase, with the full-year FY2022 number at $5.0 million, up 20.02% from a year prior.
  • Other Non-Current Liabilities hit $4.5 million in Q2 2022 for Argan, down from $5.0 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for AGX hit a ceiling of $5.0 million in Q1 2022 and a floor of $960000.0 in Q1 2019.
  • Historically, Other Non-Current Liabilities has averaged $3.1 million across 4 years, with a median of $3.3 million in 2020.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 157.92% in 2020 and later grew 16.41% in 2021.
  • Tracing AGX's Other Non-Current Liabilities over 4 years: stood at $1.8 million in 2019, then skyrocketed by 87.41% to $3.3 million in 2020, then rose by 25.37% to $4.2 million in 2021, then grew by 8.21% to $4.5 million in 2022.
  • Business Quant data shows Other Non-Current Liabilities for AGX at $4.5 million in Q2 2022, $5.0 million in Q1 2022, and $4.2 million in Q4 2021.